Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
International Ophthalmology
Erschienen in: International Ophthalmology 1/2024

01.12.2024 | Original Paper

The influencer effect of Dexmedetomidine on radioiodine relevant to lacrimal gland impairment

verfasst von: Evin Şingar, Aylin Akbulut, Gökhan Koca, Nuray Yazihan, Hasan İkbal Atilgan, Nihat Yumuşak, Ayten Demir, Ayse Burcu, Meliha Korkmaz

Erschienen in: International Ophthalmology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess the potential influencing effects of Dexmedetomidine on impaired lacrimal glands after high-dose radioiodine treatment (RAI).

Methods

Thirty-six rats were arbitrarily separated into 3 groups: Sham, RAI, and Dexmedetomidine. Dexmedetomidine group was given Dexmedetomidine and RAI, the Sham group was given the same millimeters of saline, and the RAI group was given RAI only. All forms of lacrimal glands, including harderian glands (HG), extraorbital (EG), and intraorbital (IG) lacrimal glands, were evaluated for immunohistochemical, histopathologic assessments and also for tissue cytokines, oxidant and antioxidant levels.

Results

Dexmedetomidine significantly ameliorated histopathologic changes such as periacinar fibrosis, acinar atrophy, lymphocytic infiltration, ductal proliferation, lipofuscin-like accumulation, and nucleus changes caused by RAI in all lacrimal gland forms (p < 0.05 for all of the parameters). However, periductal fibrosis was improved significantly only in EG (p = 0.049), and mast cell infiltration was improved significantly only in IG (p = 0.038) in Dexmedetomidine groups. There was a significant decrease in the elevated caspase-3 and TUNEL levels after RAI administration in the Dexmedetomidine group in all lacrimal gland forms (p < 0.05 for all parameters). Dexmedetomidine attenuated NF-kb, TNF-α, and IL-6 levels significantly diminished total oxidant status and raised total antioxidant status levels (p < 0.05 for all parameters).

Conclusions

The results of this study demonstrated that following RAI, Dexmedetomidine diminished inflammation, tissue cytokine levels, and apoptosis and ameliorated impaired histopathologic patterns of the lacrimal glands.
Literatur
1.
2.
Spitzweg C, Joba W, Schriever K et al (1999) Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands. J Clin Endocrinol Metab 84:4178–4184PubMed
3.
Bakheet SM, Hammami MM, Hemidan A et al (1998) Radioiodine secretion in tears. J Nucl Med 39:1452–1454PubMed
4.
Solans R, Bosch JA, Galofré P et al (2001) Salivary and lacrimal gland disfunction (sicca syndrome) after radioiodine therapy. J Nuc Med 42:738–743
5.
Sakahara H, Yamashita S, Suzuki K et al (2007) Visualization of nasolacrimal drainage system after radioiodine therapy in patients with thyroid cancer. Ann Nucl Med 21:525–527PubMedCrossRef
6.
Kloos RT, Duvuuri V, Jhiang SM et al (2002) Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma. J Clin Endocrinol Metab 87:5817–5820PubMedCrossRef
7.
Zettinig G, Hanselmayer G, Fueger BJ et al (2002) Long-term impairment of the lacrimal glands after radioiodine therapy: a crosssectional study. Eur J Nucl Med Mol Imaging 29:1428–1432PubMedCrossRef
8.
Bonnema SJ, Hegedüs L (2012) Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome. Endocr Rev 33(6):920–980PubMedCrossRef
9.
Koca G, Acar U, Atilgan HI et al (2013) Changes in conjunctival cytology and tear function tests with radioiodine treatment for hyperthyroidism. Ann Nucl Med 27:694–699PubMedCrossRef
10.
Dardalas I, Stamoula E, Rigopoulos P et al (2019) Dexmedetomidine effects in different experimental sepsis in vivo models. Eur J Pharmacol 856:172401PubMedCrossRef
11.
Kismet K, Sadic M, Bag YM, et al. (2016) Hepatoprotective effect of Dexmedetomidine against radioiodine toxicity in rats: evaluation of oxidative status and histopathological changes. Int Surg
12.
Liang H, Liu HZ, Wang HB et al (2017) Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation. Inflamm Res 66(5):399–411PubMedCrossRef
13.
Smith TA, Kirkpatrick DR, Smith S et al (2017) Radioprotective agents to prevent cellular damage due to ionizing radiation. J Transl Med 15(1):232PubMedPubMedCentralCrossRef
14.
Engelhard K, Werner C, Eberspächer E et al (2003) The effect of the alpha 2-agonist Dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg 96(2):524–531PubMed
15.
Çınar S, Tümkaya L, Mercantepe T et al (2021) Can Dexmedetomidine be effective in the protection of radiotherapy-induced brain damage in the rat? Neurotox Res 39(4):1338–1351PubMedCrossRef
16.
Kucuk A, Yaylak F, Cavunt-Bayraktar A et al (2014) The protective effects of Dexmedetomidine on hepatic ischemia reperfusion injury. Bratisl Lek Listy 115(11):680–684PubMed
17.
Kuru S, Barlas AM, Bozkirli B et al (2014) The protective effects of Dexmedetomidine on the liver against obstructive jaundice in rats. Acta Medica Mediterranea 30:1255–1262
18.
Wang H, Hu B, Zou Y et al (2014) Dexmedetomidine premedication attenuates concanavalin A-induced hepatitis in mice. J Toxicol Sci 39(5):755–764PubMedCrossRef
19.
Damato BE, Allan D, Murray SB, Lee WR (1984) Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease. Br J Ophthalmol 68(9):674–680PubMedPubMedCentralCrossRef
20.
Rios JD, Horikawa Y, Chen LL et al (2005) Age-dependent alterations in mouse exorbital lacrimal gland structure, innervation and secretory response. Exp Eye Res 80(4):477–491PubMedPubMedCentralCrossRef
21.
Koca G, Singar E, Akbulut A et al (2021) The effect of resveratrol on radioiodine therapy-associated lacrimal gland damage. Curr Eye Res 46(3):398–407PubMedCrossRef
22.
Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37(4):277–285PubMedCrossRef
23.
Erel O (2005) A new automated colorimetric method for measuring total oxidand status. Clin Biochem 38(12):1103–1111PubMedCrossRef
24.
25.
Li C, Wright MM, Jackson RM (2002) Reactive species mediated injury of human lung epithelial cells after hypoxia-reoxygenation. Exp Lung Res 28(5):373–389PubMedCrossRef
26.
McCord JM (1985) Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312(3):159–163PubMedCrossRef
27.
Naziroğlu M, Simşek M, Kutlu M (2004) Moderate exercise with a dietary vitamin C and E combination protects against streptozotocin-induced oxidative damage to the blood and improves fetal outcomes in pregnant rats. Clin Chem Lab Med 42(5):511–517PubMedCrossRef
28.
Eren L, Naziroglu M, Demirdas A (2007) Protectice effects of lamotrigine, aripiprazole and escitalopramon depression­ induced oxidative stress in ratbrain. Neurochem Res 32(7):1188–1195PubMedCrossRef
29.
Baysal Z, Togrul T, Aksoy N et al (2009) Evaluation of total oxidative and antioxidative status in pediatric patients undergoing laparoscopic surgery. J Pediatr Surg 44(7):1367–1370PubMedCrossRef
30.
Jones BM, Kwok CC, Kung AW (1999) Effect of radioactive iodine therapy on cytokine production in Graves’ disease: transient increases in interleukin-4 (IL-4), IL-6, IL-10, and tumor necrosis factor-alpha, with longer term increases in interferon-gamma production. J Clin Endocrinol Metab 84:4106–4110PubMed
31.
Williams RM, Singh J, Sharkey KA (1994) Innervation and mast cells of the rat exorbital lacrimal gland: the effect of age. J Auton Nerv Syst 47:95–108PubMedCrossRef
32.
Burd PR, Rogers HW, Gordon JR et al (1989) Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 170:245–257PubMedCrossRef
33.
Gordon JR, Galli SJ (1990) Mast cells as a source of both preformed and immunologically inducible TNFalpha/cachectin. Nature 346:274–276ADSPubMedCrossRef
34.
Gordon JR, Galli SJ (1991) Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J Exp Med. 174:103–107PubMedCrossRef
35.
Jaatinen P, Koistinaho J, Hervonen A (1989) Age-related morphometric and histochemical features of rat sympathetic neurons. Adv Exp Med Biol 266:61–72PubMed
36.
37.
38.
Shalini S, Dorstyn L, Dawar S et al (2015) Old, new and emerging functions of caspases. Cell Death Differ 22:526–539PubMedCrossRef
39.
Pordanjani SM, Hosseinimehr SJ (2016) The role of NF-kb inhibitors in cell response to radiation. Curr Med Chem 23(34):3951–3963PubMedCrossRef
40.
Yumusak N, Sadic M, Yucel G et al (2018) Apoptosis and cell proliferation in short-term and long-term effects of radioiodine-131-induced kidney damage: an experimental and immunohistochemical study. Nucl Med Commun 39(2):131–139PubMedCrossRef
41.
Kluck RM, Bossy-Wetzel E, Green DR et al (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132–1136PubMedCrossRef
42.
Yang J, Liu X, Bhalla K et al (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129–1132PubMedCrossRef
43.
44.
Susin SA, Zamzami N, Castedo M et al (1996) Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 184:1331–1341PubMedCrossRef
45.
Xiang J, Chao DT, Korsmeyer SJ (1996) BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc Natl Acad Sci U S A 93(25):14559–14563ADSPubMedPubMedCentralCrossRef
Metadaten
Titel
The influencer effect of Dexmedetomidine on radioiodine relevant to lacrimal gland impairment
verfasst von
Evin Şingar
Aylin Akbulut
Gökhan Koca
Nuray Yazihan
Hasan İkbal Atilgan
Nihat Yumuşak
Ayten Demir
Ayse Burcu
Meliha Korkmaz
Publikationsdatum
01.12.2024
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 1/2024
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-024-03052-6

Weitere Artikel der Ausgabe 1/2024

International Ophthalmology 1/2024 Zur Ausgabe

Original Paper

Visual performance and patient preference with bilateral implantation of an extended depth of focus or combined implantation of an extended depth of focus/trifocal intraocular lens

Original Paper

Visualization and analysis of mapping knowledge domains for optic neuritis: a bibliometric research from 2013 to 2022

Case Report

Clinical outcomes of traumatic globe rupture in corneal graft patients

Original Paper

High-throughput screening of transient receptor potential (TRP) channels in pterygium

Original Paper

Applications of topical immunomodulators enhance clinical signs of vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC): a meta-analysis

Review

Ocular manifestations of liver disease: an important diagnostic aid

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen